Search results
Results from the WOW.Com Content Network
Leafly is a website focused on cannabis use and education. [3] The company says it has more than 120 million annual visitors and over 10 million monthly active users. [ 4 ] Leafly provides a wide range of information on cannabis including 1.5 million consumer product reviews, more than 9,000 cannabis articles and resources, and over 5,000 ...
Mark Stepnoski, former All-Pro offensive lineman for the Dallas Cowboys and Houston Oilers, served as president of the Texas chapter of the National Organization for the Reform of Marijuana Laws (Texas NORML) during the early 2000s. [100] [101] Texas Cannabis Collective, a pro-legalization group, was founded in 2016. [102]
Privateer Holdings acquired Leafly in 2011. In 2014, Leafly became the first cannabis company to place an advertisement in the New York Times. [8] Privateer owns 76 percent of Tilray Inc., [9] a company federally licensed by the Government of Canada to produce, process, package and distribute medical cannabis. The company operates a 60,000 sq ...
Here’s what’s allowed by Texas law, and how medical marijuana dispensaries work. Skip to main content. Sign in. Mail. 24/7 Help. For premium support please call: 800-290-4726 ...
Possession of up to 20 g (3 ⁄ 4 oz) of marijuana or 5 g (3 ⁄ 16 oz) of genetically modified marijuana for commercial purposes is punishable by 1–2 years in prison at judge's discretion. If deemed to be for personal consumption, the user is subject to security measures involving rehabilitation and detoxification procedures.
For premium support please call: 800-290-4726 more ways to reach us
Cannabis intoxication limits vary by state — anywhere from zero to 5 nanograms per milliliter of blood. But most clinical researchers say those numbers don’t correlate with impairment.
Cannabis was commonly sold in tincture form by Parke-Davis, Eli Lilly, E. R. Squibb & Sons, and other drug manufacturers. [10] [11] By the end of the 19th century, the use of cannabis in medicine had declined due to a number of factors, including difficulty in controlling dosages and the rise in popularity of synthetic and opium-derived drugs. [9]